Diffuse large B cell lymphoma (DLBCL) in Pakistan: an emerging epidemic?
- PMID: 16436006
Diffuse large B cell lymphoma (DLBCL) in Pakistan: an emerging epidemic?
Abstract
There has been a recent concern among oncological clinicians and pathologists of our region regarding the disproportionate increase in the number of patients presenting with diffuse large B cell lymphoma (DLBCL). This prompted us to conduct a thorough, hospital-based epidemiological study in a major referral center of Pakistan. A total of 780 specimens were collected over last half decade from cases classified as adult Non Hodgkin's lymphoma (NHL). Out of these 780, 596 (76.4 %) were diagnosed as DLBCLs. The gender ratio was 2.3:1 (M:F) and the median age was 47.2 years, with an age range of 15-85 years. Nodal-NHLs constituted 42.2 % of all adult NHLs, with the cervical lymph nodes as the most frequent nodal site of presentation. The most frequent extranodal site was the gastro-intestinal tract (GIT), followed by the head and neck. In conclusion, we document an astonishingly high number of DLBCL amounting to an emerging epidemic in Pakistan, with a consideration of probable etiopathogenetic factors.
Similar articles
-
Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):453-8. Asian Pac J Cancer Prev. 2008. PMID: 19004134
-
Site-specific analysis of B-cell non-Hodgkin's lymphomas of the head and neck: A retrospective 10-year observation.Acta Otolaryngol. 2015;135(11):1168-71. doi: 10.3109/00016489.2015.1061700. Epub 2015 Jun 25. Acta Otolaryngol. 2015. PMID: 26113048
-
Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.Hum Pathol. 2001 Sep;32(9):954-62. doi: 10.1053/hupa.2001.27118. Hum Pathol. 2001. PMID: 11567225
-
Diffuse large B-cell lymphoma.Crit Rev Oncol Hematol. 2013 Aug;87(2):146-71. doi: 10.1016/j.critrevonc.2012.12.009. Epub 2013 Jan 30. Crit Rev Oncol Hematol. 2013. PMID: 23375551 Review.
-
Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.Mod Pathol. 2000 Jan;13(1):19-28. doi: 10.1038/modpathol.3880005. Mod Pathol. 2000. PMID: 10658906 Review.
Cited by
-
Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells.Oncol Lett. 2015 Apr;9(4):1940-1946. doi: 10.3892/ol.2015.2941. Epub 2015 Feb 9. Oncol Lett. 2015. PMID: 25789073 Free PMC article.
-
The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1103-1107. doi: 10.31557/APJCP.2020.21.4.1103. Asian Pac J Cancer Prev. 2020. PMID: 32334477 Free PMC article.
-
Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review.Discov Oncol. 2025 Feb 15;16(1):184. doi: 10.1007/s12672-025-01958-w. Discov Oncol. 2025. PMID: 39954204 Free PMC article. Review.
-
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.Leuk Res Rep. 2021 Nov 29;16:100284. doi: 10.1016/j.lrr.2021.100284. eCollection 2021. Leuk Res Rep. 2021. PMID: 34926144 Free PMC article.
-
Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database.Indian J Hematol Blood Transfus. 2024 Apr;40(2):220-230. doi: 10.1007/s12288-023-01706-6. Epub 2024 Jan 3. Indian J Hematol Blood Transfus. 2024. PMID: 38708154 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources